Home » Topics » BioWorld

BioWorld
RSS

VESTAR DONATES DRUG TO KS PATIENTS

Jan. 19, 1993

SUGEN JOINS FORCES WITH SELECTIDE

Jan. 19, 1993

CENTOCOR HALTS TRIALS; STOCK PLUMMETS

Jan. 19, 1993

TLC UNDERWRITERS EXERCISE OPTION

Jan. 18, 1993

EPA PROPOSES REDUCED REGULATIONS FOR FIELD TRIALS

Jan. 18, 1993

FOCAL RAISES $9.2 MILLION IN PRIVATE PLACEMENT

Jan. 18, 1993

NORSK WITHDRAWS FROM DEAL WITH TELIOS

Jan. 18, 1993

EUROPEAN PATENT DISLOSURES

Jan. 18, 1993

CYTRX FORMS SUBSIDIARY

Jan. 18, 1993

MEDCLONE MAB DESIGNATED ORPHAN DRUG

Jan. 18, 1993

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...